Biogen Inc. (BIIB) Q4 2008 Earnings Results

Biogen Inc. Beats on EPS, Stock Down 1.5%

Biogen's earnings report showed a slight beat on EPS, which indicates better-than-expected profitability. However, the stock reacted negatively, declining by 1.5%. This drop may reflect investor concerns over the lack of revenue data and guidance, leaving uncertainty about the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.93	N/A	+4.85%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Biogen Inc. Beats on EPS, Stock Down 1.5%

Key numbers

Management commentary

Biogen Inc.

More earnings this week

Biogen Inc. Beats on EPS, Stock Down 1.5%

Key numbers

Management commentary